Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K L Goa

Showing results (141-150 of 189) with videos related to

Pageof 19
Sort By:
Drugs & Aging|November 1, 1993
Epalrestat. A review of its pharmacology, and therapeutic potential in late-onset complications of diabetes mellitusJ W Steele, D Faulds, K L Goa
Drugs|April 1, 1996
Itraconazole. A reappraisal of its pharmacological properties and therapeutic use in the management of superficial fungal infectionsM Haria, H M Bryson, K L Goa
Drugs|March 1, 1993
Mifepristone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potentialR N Brogden, K L Goa, D Faulds
Drugs|September 18, 2001
Cefuroxime axetil: an updated review of its use in the management of bacterial infectionsL J Scott, D Ormrod, K L Goa
Drugs|November 21, 2000
Nicorandil. An updated review of its use in ischaemic heart disease with emphasis on its cardioprotective effectsA Markham, G L Plosker, K L Goa
Drugs|February 24, 2001
Inhaled budesonide/formoterol combinationJ K McGavin, K L Goa, B Jarvis
Drugs|July 1, 1995
Transnasal butorphanol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in acute pain managementJ C Gillis, P Benfield, K L Goa
Pharmacoeconomics|December 8, 1996
Simvastatin. A reappraisal of its cost effectiveness in dyslipidaemia and coronary heart diseaseK L Goa, L B Barradell, D McTavish
Drugs|April 1, 1997
Octreotide long-acting release (LAR). A review of its pharmacological properties and therapeutic use in the management of acromegalyJ C Gillis, S Noble, K L Goa
Drugs|April 1, 1997
Sparfloxacin. A review of its antibacterial activity, pharmacokinetic properties, clinical efficacy and tolerability in lower respiratory tract infectionsK L Goa, H M Bryson, A Markham
Pageof 19

Showing results (141-150 of 189) with videos related to

Sort By:
Pageof 19
Drugs & Aging|November 1, 1993
Epalrestat. A review of its pharmacology, and therapeutic potential in late-onset complications of diabetes mellitusJ W Steele, D Faulds, K L Goa
Drugs|April 1, 1996
Itraconazole. A reappraisal of its pharmacological properties and therapeutic use in the management of superficial fungal infectionsM Haria, H M Bryson, K L Goa
Drugs|March 1, 1993
Mifepristone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potentialR N Brogden, K L Goa, D Faulds
Drugs|September 18, 2001
Cefuroxime axetil: an updated review of its use in the management of bacterial infectionsL J Scott, D Ormrod, K L Goa
Drugs|November 21, 2000
Nicorandil. An updated review of its use in ischaemic heart disease with emphasis on its cardioprotective effectsA Markham, G L Plosker, K L Goa
Drugs|February 24, 2001
Inhaled budesonide/formoterol combinationJ K McGavin, K L Goa, B Jarvis
Drugs|July 1, 1995
Transnasal butorphanol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in acute pain managementJ C Gillis, P Benfield, K L Goa
Pharmacoeconomics|December 8, 1996
Simvastatin. A reappraisal of its cost effectiveness in dyslipidaemia and coronary heart diseaseK L Goa, L B Barradell, D McTavish
Drugs|April 1, 1997
Octreotide long-acting release (LAR). A review of its pharmacological properties and therapeutic use in the management of acromegalyJ C Gillis, S Noble, K L Goa
Drugs|April 1, 1997
Sparfloxacin. A review of its antibacterial activity, pharmacokinetic properties, clinical efficacy and tolerability in lower respiratory tract infectionsK L Goa, H M Bryson, A Markham
Pageof 19